||This biography of a living person needs additional citations for verification. (February 2012) (Learn how and when to remove this template message)|
||This article may require cleanup to meet Wikipedia's quality standards. The specific problem is: The external links syntax is being used in article text, probably where references are intended. See WP:CITE for instructions on how to create references, I've added one to demonstrate. (July 2012) (Learn how and when to remove this template message)|
Stephen Globus is a New York City venture capitalist who is third generation from a prominent banking family. He is currently a founder and director of China Biopharmaceuticals Holdings, which is a major medical company in China. He was a founding shareholder of Genitope Corporation which is a San Francisco-area biotechnology company that designs custom treatments for cancer, including a vaccine to treat lymphoma.
Globus also was founder and chairman of PlasmaCo which developed color plasma television and sold to Osaka based Matsushita (Panasonic) in 1996. Globus was on the Japanese Board of Directors for the proceeding 7 years after the sale. His other ventures activities include key investment or managerial roles in Proscure (sold to Repligen), ExSar, Kimeragen which sold to a Paris-based company whose board Globus served on, Energy Research (Fuel Cell Energy), Nematron, and Tinsley Laboratories which developed the optic correction for Hubble Space Telescope now a division of the Dutch company ASML .
Globus holds patents on panoramic cameras called the Globuscope and optics. Globus is a founder of Globus Studios in Central Manhattan. He is patron of the arts with associations such as Japan Society of New York and China Institute in America.